🔎 Trials Near Me

Domov › Rak pljuč › South Carolina

Klinične študije za Rak pljuč v South Carolina

19 študij za Rak pljuč išče udeležence na lokacijah v South Carolina.

Mesta v South Carolina

Uradno besedilo študije (angleško)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Saint Joseph's/Candler - Bluffton Campus, Bluffton
  • Prisma Health Cancer Institute - Spartanburg, Boiling Springs
  • Bon Secours Saint Francis Hospital, Charleston
  • in še 15
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • AnMed Health Cancer Center, Anderson
  • Prisma Health Richland Hospital, Columbia
  • McLeod Regional Medical Center, Florence
  • in še 12
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 40–75 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

  • Ralph H Johnson VA Medical Center, Charleston
  • Medical University of South Carolina, Charleston
Vključevanje udeležencevFaza 3
Starost 70 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06096844

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Prisma Health Cancer Institute - Spartanburg, Boiling Springs
  • Prisma Health Cancer Institute - Easley, Easley
  • Gibbs Cancer Center-Gaffney, Gaffney
  • in še 9
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06498635

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

  • Saint Joseph's Candler Health System ( Site 4010), Bluffton
  • Medical University of South Carolina-Hollings Cancer Center ( Site 0045), Charleston
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06312137

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

  • Medical University of South Carolina, Florence
  • Medical University of South Carolina Health Lancaster Medical Center, Lancaster
Vključevanje udeležencevFaza 3
Starost 18–100 · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT05920356

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Medical University of South Carolina, Charleston
  • Prisma Health Cancer Institute, Greenville
  • Lexington Medical Center, West Columbia
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06119581

Health Education Approach to Lung Screening

  • Medical University of South Carolina, Charleston
Vključevanje udeležencevVabljeni zdravi prostovoljci
Starost 50–80 · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT06070870

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

  • Saint Joseph's/Candler - Bluffton Campus, Bluffton
  • Gibbs Cancer Center-Gaffney, Gaffney
  • Saint Francis Hospital, Greenville
  • in še 8
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT05624996

Prediction Augmented Screening Initiative

  • Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
Vključevanje udeležencev
Starost 50–80 · Vsi spoli · Posodobljeno 26. jun. 2026 · NCT06538636

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • AnMed Health Cancer Center, Anderson
  • Saint Joseph's/Candler - Bluffton Campus, Bluffton
  • Prisma Health Cancer Institute - Spartanburg, Boiling Springs
  • in še 9
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 3. jun. 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

  • AnMed Health Cancer Center, Anderson
Vključevanje udeležencevFaza 2
18 Minutes · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

  • AnMed Health Cancer Center, Anderson
  • Saint Joseph's/Candler - Bluffton Campus, Bluffton
  • Medical University of South Carolina, Charleston
  • in še 5
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06616584

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Medical University of South Carolina, Charleston
  • McLeod Health, Florence
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
Starost 40 in več · Vsi spoli · Posodobljeno 20. jan. 2026 · NCT05366881

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

  • AnMed Health Cancer Center, Anderson
  • Saint Joseph's/Candler - Bluffton Campus, Bluffton
  • Gibbs Cancer Center-Gaffney, Gaffney
  • in še 7
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 9. jan. 2026 · NCT06073431

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Greenville
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 28. okt. 2025 · NCT03452774

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

  • Medical University of South Carolina (MUSC), Charleston
  • McLeod Health, Florence
Vključevanje udeležencevOpazovalna študija
Starost 50 in več · Vsi spoli · Posodobljeno 5. avg. 2025 · NCT06122077

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

  • Ralph H. Johnson VA Health Care System, Charleston
Vključevanje udeležencevOpazovalna študija
Starost 29–85 · Vsi spoli · Posodobljeno 13. nov. 2024 · NCT06426628

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.